May 10th 2024
From Big Pharma to biotech—and a globe-spanning journey along the way—Yvonne Greenstreet, this year’s Healthcare Businesswomen’s Association Woman of the Year, is right where she wants to be: leading efforts to advance “bold ideas” in RNAi therapeutics into life-changing gains for patients.
Chasing Breakthroughs in I&I: Pfizer’s Mike Gladstone
May 11th 2021Mike Gladstone, Pfizer’s Global President of Inflammation & Immunology (I&I), talks about how the company is addressing the unmet need in I&I and how its relationships with patients is fueling the quest for breakthroughs over ‘me too’ incremental improvements
Sam Pearce: Joining the Jigsaw Pieces at Jazz
February 1st 2021Sam Pearce, SVP, Head of Europe and International at Jazz Pharmaceuticals, talks about joining the company during a transformative period and how she is working to foster a bold and collaborative culture to expand Jazz’s footprint in Europe and beyond.
Hooked on Gene Therapy: Kevin Foust, Novartis
December 22nd 2020Kevin Foust, Senior Director of Research & Early Development at Novartis Gene Therapies, talks to Pharm Exec about his involvement in the development of Zolgensma, the first and only gene therapy approved to treat spinal muscular atrophy (SMA).
Rare Insights: Arndt Rolfs, CENTOGENE
June 10th 2020Pharm Exec speaks with Arndt Rolfs, CEO and founder of CENTOGENE, who discusses his company’s rise from a small genetic diagnostics startup to a global organization focused on advancing the understanding of the pathophysiology of rare hereditary diseases.
HBA's Woman of the Year 2020: A Motivated Mission
April 23rd 2020For Sandra Horning, this year's Healthcare Businesswomen’s Association Woman of the Year, harnessing the patient experience has been the driving force in a career-spanning-and service-focused-mission to fight disease and accelerate the delivery of new medicines.